![Primary and Secondary Prevention of Ischemic Stroke and Cerebral Hemorrhage: JACC Focus Seminar - ScienceDirect Primary and Secondary Prevention of Ischemic Stroke and Cerebral Hemorrhage: JACC Focus Seminar - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109720344260-fx1.jpg)
Primary and Secondary Prevention of Ischemic Stroke and Cerebral Hemorrhage: JACC Focus Seminar - ScienceDirect
Appraising the contemporary role of aspirin for primary and secondary prevention of atherosclerotic cardiovascular events
![Highlights from the 2019 International Aspirin Foundation Scientific Conference, Rome, 28 June 2019: benefits and risks of antithrombotic therapy for cardiovasc Highlights from the 2019 International Aspirin Foundation Scientific Conference, Rome, 28 June 2019: benefits and risks of antithrombotic therapy for cardiovasc](https://ecancer.org/en/journal/article/site/data/images/article/1003/can-14-998fig2.gif)
Highlights from the 2019 International Aspirin Foundation Scientific Conference, Rome, 28 June 2019: benefits and risks of antithrombotic therapy for cardiovasc
![P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events | Journal of the American College of Cardiology P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/2a299f30-d123-45a6-b68a-c12d3a79d86d/fx1.jpg)
P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events | Journal of the American College of Cardiology
![Aspirin for primary prevention of atherosclerotic cardiovascular events | Cleveland Clinic Journal of Medicine Aspirin for primary prevention of atherosclerotic cardiovascular events | Cleveland Clinic Journal of Medicine](https://www.ccjm.org/content/ccjom/87/5/300/F1.large.jpg)
Aspirin for primary prevention of atherosclerotic cardiovascular events | Cleveland Clinic Journal of Medicine
![Aspirin for Primary and Secondary Prevention of Mortality, Cardiovascular Disease, and Kidney Failure in the Chronic Renal Insufficiency Cohort (CRIC) Study - ScienceDirect Aspirin for Primary and Secondary Prevention of Mortality, Cardiovascular Disease, and Kidney Failure in the Chronic Renal Insufficiency Cohort (CRIC) Study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S259005952200173X-gr1.jpg)
Aspirin for Primary and Secondary Prevention of Mortality, Cardiovascular Disease, and Kidney Failure in the Chronic Renal Insufficiency Cohort (CRIC) Study - ScienceDirect
![Frontiers | Personalized allocation of acetylsalicylic acid therapy for secondary prevention of coronary artery disease Frontiers | Personalized allocation of acetylsalicylic acid therapy for secondary prevention of coronary artery disease](https://www.frontiersin.org/files/Articles/1004473/fcvm-09-1004473-HTML/image_m/fcvm-09-1004473-g002.jpg)
Frontiers | Personalized allocation of acetylsalicylic acid therapy for secondary prevention of coronary artery disease
![Low-dose aspirin for primary and secondary prevention of cardiovascular events in Denmark 1998–2018 | Scientific Reports Low-dose aspirin for primary and secondary prevention of cardiovascular events in Denmark 1998–2018 | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-021-93179-8/MediaObjects/41598_2021_93179_Fig5_HTML.png)
Low-dose aspirin for primary and secondary prevention of cardiovascular events in Denmark 1998–2018 | Scientific Reports
![Aspirin for Primary and Secondary Prevention of Mortality, Cardiovascular Disease, and Kidney Failure in the Chronic Renal Insufficiency Cohort (CRIC) Study - ScienceDirect Aspirin for Primary and Secondary Prevention of Mortality, Cardiovascular Disease, and Kidney Failure in the Chronic Renal Insufficiency Cohort (CRIC) Study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S259005952200173X-fx1.jpg)
Aspirin for Primary and Secondary Prevention of Mortality, Cardiovascular Disease, and Kidney Failure in the Chronic Renal Insufficiency Cohort (CRIC) Study - ScienceDirect
![Full article: Appraising the contemporary role of aspirin for primary and secondary prevention of atherosclerotic cardiovascular events Full article: Appraising the contemporary role of aspirin for primary and secondary prevention of atherosclerotic cardiovascular events](https://www.tandfonline.com/cms/asset/844104e8-d73a-4cf8-8e38-84a0a95d7bab/ierk_a_2020100_f0003_oc.jpg)
Full article: Appraising the contemporary role of aspirin for primary and secondary prevention of atherosclerotic cardiovascular events
![PDF] Aspirin: Its risks, benefits, and optimal use in preventing cardiovascular events | Semantic Scholar PDF] Aspirin: Its risks, benefits, and optimal use in preventing cardiovascular events | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d0d1a9da91bb2852125f3fe77a8eb24002b62415/6-Figure1-1.png)
PDF] Aspirin: Its risks, benefits, and optimal use in preventing cardiovascular events | Semantic Scholar
![Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis - The Lancet Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis - The Lancet](https://www.thelancet.com/cms/attachment/f58a1e92-6f18-456b-b74a-0a87e1f7ca10/gr1_lrg.gif)